文献速递介入外周血管腹部USDSA

经颈静脉肝内门体分流术创建中联合或不联合血管内超声引导的Meta分析

Meta-analysis of transjugular intrahepatic portosystemic shunt creation with or without intravascular ultrasound guidance.
PubMed 文献 · Br J Radiol · 2024-01-01

该Meta分析纳入6项比较研究(IVUS组194例,非IVUS组240例),评估血管内超声(IVUS)在经颈静脉肝内门体分流术(TIPS)创建中的效用。汇总分析显示IVUS引导可缩短总手术时间、门静脉穿刺时间、透视时间,减少碘对比剂用量、空气比释动能和剂量面积乘积;穿刺针次数在两组间无显著差异(4.2 vs 7.8,P=.134),并发症发生率分别为15.2%(12/79)和21.4%(28/131)。结论认为IVUS引导改善了手术指标,且不增加并发症率。

要点

  • IVUS引导TIPS可缩短总手术时间(SMD -0.76,P<.001)和门静脉穿刺时间(SMD -0.41,P=.002)。
  • IVUS引导减少透视时间(SMD -0.54,P=.002)、对比剂用量(SMD -0.89,P<.001)及辐射剂量指标。
  • 穿刺针次数IVUS组4.2次 vs 非IVUS组7.8次,差异未达统计学显著(SMD -0.60,P=.134)。

核心结论

  • TIPS创建中IVUS引导可改善手术指标,包括手术时间、对比剂用量和辐射暴露;IVUS使用与并发症率升高无关。

研究设计与样本

  • Meta分析,检索MEDLINE和Embase数据库至2022年7月,纳入6项比较研究,IVUS组194例、非IVUS组240例,采用随机效应模型汇总手术指标。

诊断标准与关键数值

  • IVUS组 vs 非IVUS组:总手术时间SMD -0.76(95%CI -1.02, -0.50),P<.001。
  • IVUS组 vs 非IVUS组:门静脉穿刺时间SMD -0.41(95%CI -0.67, -0.15),P=.002。
  • IVUS组 vs 非IVUS组:透视时间SMD -0.54(95%CI -1.02, -0.07),P=.002。
  • IVUS组 vs 非IVUS组:对比剂用量SMD -0.89(95%CI -1.16, -0.63),P<.001;空气比释动能SMD -0.75(95%CI -1.11, -0.38),P<.001;剂量面积乘积SMD -0.98(95%CI -1.77, -0.20),P=.013。
  • 穿刺针次数IVUS组4.2次 vs 非IVUS组7.8次,SMD -0.60(95%CI -1.42, 0.21),P=.134,未达统计学显著;并发症率IVUS组15.2%(12/79) vs 非IVUS组21.4%(28/131)。

临床应用与阅片要点

  • 作者结论认为IVUS引导TIPS创建可改善手术时间、对比剂用量和辐射暴露等指标。
  • 作者指出IVUS使用与并发症率升高无关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To conduct a meta-analysis to assess the efficacy of intravascular ultrasound (IVUS) during transjugular intrahepatic portosystemic shunt (TIPS) creation.

METHODS: MEDLINE and Embase databases were queried until July 2022 for comparative studies reporting procedure metrics for TIPS creation with or without IVUS guidance. Meta-analysis was performed with random-effects modelling for total procedural time, time to portal venous access, fluoroscopy time, iodinated contrast volume use, air kerma, dose area product, and number of needle passes. Intraoperative procedure-related complications were also reviewed.

RESULTS: Of 95 unique records initially identified, 6 were eligible for inclusion. A total of 194 and 240 patients underwent TIPS with and without IVUS guidance. Pooled analyses indicated that IVUS guidance was associated with reduced total procedure time (SMD -0.76 [95% CI -1.02, -0.50] P < .001), time to portal venous access (SMD -0.41 [95% CI -0.67, -0.15] P = .002), fluoroscopy time (SMD, -0.54 [95% CI -1.02, -0.07]; P = .002), contrast volume use (SMD, -0.89 [95% CI -1.16, -0.63]; P < .001), air kerma (SMD, -0.75 [95% CI -1.11, -0.38]; P < .001) and dose area product (SMD, -0.98 [95% CI -1.77, -0.20]; P = .013). A total of 4.2 and 7.8 needle passes were required in the IVUS and non-IVUS group, respectively (SMD, -0.60 [95% CI -1.42, 0.21]; P = .134). Pooled complication rates were 15.2% (12/79) and 21.4% (28/131), respectively.

CONCLUSION: IVUS guidance during TIPS creation improves procedural metrics including procedural time, contrast usage, and radiation exposure.

ADVANCES IN KNOWLEDGE: (1) The use of IVUS during TIPS is associated with shorter procedural time, lower contrast usage, and radiation exposure. (2)The use of IVUS is not associated with higher complication rates.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Yu Q, Ahmed O, Gutti S, et al. Meta-analysis of transjugular intrahepatic portosystemic shunt creation with or without intravascular ultrasound guidance. Br J Radiol. 2024. PMID: 38588565. doi:10.1093/bjr/tqae074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。